search
Back to results

COVID-19 Health Messaging to Underserved Communities

Primary Purpose

Coronavirus

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Messaging
Sponsored by
National Bureau of Economic Research, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Coronavirus

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers
Inclusion Criteria: Hispanic and African-American adult individuals, men and women - oversample of those with less completed education Exclusion Criteria: children, those who do not identify as above

Sites / Locations

  • JPAL North America

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm 10

Arm 11

Arm 12

Arm 13

Arm 14

Arm 15

Arm 16

Arm 17

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Placebo Comparator

Arm Label

Control - CDC - Mask (Control) - Concordant

Control - CDC - Mask (Control) - Discordant

Control - MGH - Mask (Control) - Concordant

Control - MGH - Mask (Control) - Discordant

Ack. Discrimination- MGH - Mask (Control) - Concordant

Ack. Discrimination- MGH - Mask (Control) - Discordant

Ack. econ. circumstance- MGH - Mask (Control ) Concordant

Ack. econ. circumstance - MGH - Mask (Control ) Discordant

Control Intro - CDC - Mask (antiStigma) Concordant

Control Intro - CDC - Mask (antiStigma) Discordant

Control - MGH - MaskS (antiStigma) Concordant messenger

Control- MGH-MaskS (antiStigma) Discordant messenger

Ack. Discrimination - MGH - MaskS (antiStigma) Concordant

Ack. Discrimination - MGH - MaskS (antiStigma) Discordant

Ack. Econ Hardship- MGH - Mask (antiStigma) Concordant

Ack. Econ Hardship- MGH - Mask (antiStigma) Discordant

Info later - Pure Control

Arm Description

Control Intro, CDC Social Distancing, Mask Control version delivered by minority doctor of same background as the recipient - other definitions are similar

Control Intro, CDC Social Distancing, Mask Control version delivered by majority doctor of different background as the recipient - other definitions are similar

Control Intro, MGH Social Distancing, Mask Control version delivered by concordant doctor

Control Intro, MGH Social Distancing, Mask Control version delivered by discordant doctor

Introduction Acknowledges past discrimination, MGH doctor talks about Social Distancing, Mask Control all by concordant MD

Introduction Acknowledges past discrimination, MGH doctor talks about Social Distancing, Mask Control all by discordant MD

Intro econ. circumstance -MGH - Mask (Control ) Concordant

Control Intro - CDC - Mask (antiStigma) Concordant messenger

Control Intro - CDC - Mask (antiStigma) discordant messenger

Control - MGH - MaskS (antiStigma) Concordant sender

Control - MGH - MaskS (antiStigma) Discordant sender

Acknowledge Discrimination - MGH - MaskS (antiStigma) Concordant sender

Acknowledge Discrimination - MGH - MaskS (antiStigma) Discordant sender

Acknowledge Econ Hardship- MGH - Mask (antiStigma) Concordant sender

Acknowledge Econ Hardship- MGH - Mask (antiStigma) discordant sender

This group will not receive the videos but will receive information later.

Outcomes

Primary Outcome Measures

Incidence Rate for Knowledge Gaps: Control vs. Any Intervention
Incidence rate for knowledge gaps is the count of knowledge gaps divided by the maximum possible count: 7
Incidence Rate for Information-seeking Behavior: Control vs. Any Intervention
Incidence rate for Information-seeking behavior is the count of links demanded divided by the maximum possible count: 10
Incidence Rate for Knowledge Gaps by Intervention
Incidence rate for knowledge gaps is the count of knowledge gaps divided by the maximum possible count: 7
Incidence Rate for Information-seeking Behavior by Intervention
Incidence rate for Information-seeking behavior is the count of links demanded divided by the maximum possible count: 10

Secondary Outcome Measures

Full Information

First Posted
April 28, 2020
Last Updated
July 24, 2021
Sponsor
National Bureau of Economic Research, Inc.
Collaborators
Massachusetts General Hospital, Stanford University, Yale University, Massachusetts Institute of Technology, Harvard University
search

1. Study Identification

Unique Protocol Identification Number
NCT04371419
Brief Title
COVID-19 Health Messaging to Underserved Communities
Official Title
COVID-19 Health Messaging to Underserved Communities
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
May 13, 2020 (Actual)
Primary Completion Date
May 24, 2020 (Actual)
Study Completion Date
May 26, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Bureau of Economic Research, Inc.
Collaborators
Massachusetts General Hospital, Stanford University, Yale University, Massachusetts Institute of Technology, Harvard University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Recent data have shown that covid19 is disproportionately infecting and killing African Americans and Latinx people in the United States. The aim of the study is to determine which messages are most effective at increasing knowledge and changing behaviors that can protect individuals and their communities from the virus. To accomplish this aim, we plan to recruit approximately 20,000 Hispanic and African-American individuals and randomly assign them to videos that vary either the sender or the framing of the message, while providing the relevant public health information.
Detailed Description
The following procedures will be followed. The research subjects will participate online. Doctors from MGH who express interest in participating will record messages according to our scripts (US Doctors Script African American, US Doctors Script Latinx). They will be instructed to film several different versions each. We will recruit a sample of Latinx and African American study participants from across the country through Lucid, an online survey firm that has access to a large subject pool. Participants will first read a consent script and give us their informed consent (US Doctors Messaging Consent) Participants will then navigate through the following steps Brief demographics survey questions (US Doctors Messaging Survey) Videos 1 and 2: Introduction, Acknowledgement, Social Distancing (US Doctors Script African American, US Doctors Script Latinx). Individuals in the control group will not see videos. Beliefs survey questions (US Doctors Messaging Survey) Video 3: Masks (US Doctors Script African American, US Doctors Script Latinx). Again, individuals in the control group will not see a video here. Main outcomes survey (US Doctors Messaging Survey) Control group is shown a version of all 3 videos at end (US Doctors Script African American, US Doctors Script Latinx). The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document. Racial or ethnic identity of the doctor delivering the messages: concordant vs. discordant identity to the subject. Whether the message includes an acknowledgment of "elephant in the room" issues for each target group: trust in the medical system or fear of deportation. Whether the social distancing component of the message is delivered by Dr. Birx of the CDC or recorded by the MGH physicians. Whether individuals are given information about how representative individuals perceive mask wearers of color. This information comes from results of our nationally representative pilot survey. Some individuals in a control group will only see messages after all surveying has been completed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronavirus

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
14267 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control - CDC - Mask (Control) - Concordant
Arm Type
Experimental
Arm Description
Control Intro, CDC Social Distancing, Mask Control version delivered by minority doctor of same background as the recipient - other definitions are similar
Arm Title
Control - CDC - Mask (Control) - Discordant
Arm Type
Experimental
Arm Description
Control Intro, CDC Social Distancing, Mask Control version delivered by majority doctor of different background as the recipient - other definitions are similar
Arm Title
Control - MGH - Mask (Control) - Concordant
Arm Type
Experimental
Arm Description
Control Intro, MGH Social Distancing, Mask Control version delivered by concordant doctor
Arm Title
Control - MGH - Mask (Control) - Discordant
Arm Type
Experimental
Arm Description
Control Intro, MGH Social Distancing, Mask Control version delivered by discordant doctor
Arm Title
Ack. Discrimination- MGH - Mask (Control) - Concordant
Arm Type
Experimental
Arm Description
Introduction Acknowledges past discrimination, MGH doctor talks about Social Distancing, Mask Control all by concordant MD
Arm Title
Ack. Discrimination- MGH - Mask (Control) - Discordant
Arm Type
Experimental
Arm Description
Introduction Acknowledges past discrimination, MGH doctor talks about Social Distancing, Mask Control all by discordant MD
Arm Title
Ack. econ. circumstance- MGH - Mask (Control ) Concordant
Arm Type
Experimental
Arm Description
Intro econ. circumstance -MGH - Mask (Control ) Concordant
Arm Title
Ack. econ. circumstance - MGH - Mask (Control ) Discordant
Arm Type
Experimental
Arm Title
Control Intro - CDC - Mask (antiStigma) Concordant
Arm Type
Experimental
Arm Description
Control Intro - CDC - Mask (antiStigma) Concordant messenger
Arm Title
Control Intro - CDC - Mask (antiStigma) Discordant
Arm Type
Experimental
Arm Description
Control Intro - CDC - Mask (antiStigma) discordant messenger
Arm Title
Control - MGH - MaskS (antiStigma) Concordant messenger
Arm Type
Experimental
Arm Description
Control - MGH - MaskS (antiStigma) Concordant sender
Arm Title
Control- MGH-MaskS (antiStigma) Discordant messenger
Arm Type
Experimental
Arm Description
Control - MGH - MaskS (antiStigma) Discordant sender
Arm Title
Ack. Discrimination - MGH - MaskS (antiStigma) Concordant
Arm Type
Experimental
Arm Description
Acknowledge Discrimination - MGH - MaskS (antiStigma) Concordant sender
Arm Title
Ack. Discrimination - MGH - MaskS (antiStigma) Discordant
Arm Type
Experimental
Arm Description
Acknowledge Discrimination - MGH - MaskS (antiStigma) Discordant sender
Arm Title
Ack. Econ Hardship- MGH - Mask (antiStigma) Concordant
Arm Type
Experimental
Arm Description
Acknowledge Econ Hardship- MGH - Mask (antiStigma) Concordant sender
Arm Title
Ack. Econ Hardship- MGH - Mask (antiStigma) Discordant
Arm Type
Experimental
Arm Description
Acknowledge Econ Hardship- MGH - Mask (antiStigma) discordant sender
Arm Title
Info later - Pure Control
Arm Type
Placebo Comparator
Arm Description
This group will not receive the videos but will receive information later.
Intervention Type
Behavioral
Intervention Name(s)
Messaging
Intervention Description
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document. Racial or ethnic identity of the doctor delivering the messages: concordant vs. discordant identity to the subject. Whether the message includes an acknowledgment of "elephant in the room" issues for each target group: trust in the medical system or fear of deportation. Whether the social distancing component of the message is delivered by Dr. Birx of the CDC or recorded by the MGH physicians. Whether individuals are given information about how representative individuals perceive mask wearers of color. This information comes from results of our nationally representative pilot survey. Some individuals in a control group will see messages later.
Primary Outcome Measure Information:
Title
Incidence Rate for Knowledge Gaps: Control vs. Any Intervention
Description
Incidence rate for knowledge gaps is the count of knowledge gaps divided by the maximum possible count: 7
Time Frame
The outcome was measured immediately following the intervention in the 15-minute baseline survey.
Title
Incidence Rate for Information-seeking Behavior: Control vs. Any Intervention
Description
Incidence rate for Information-seeking behavior is the count of links demanded divided by the maximum possible count: 10
Time Frame
The outcome was measured immediately following the intervention in the 15-minute baseline survey.
Title
Incidence Rate for Knowledge Gaps by Intervention
Description
Incidence rate for knowledge gaps is the count of knowledge gaps divided by the maximum possible count: 7
Time Frame
The outcome was measured immediately following the intervention in the 15-minute baseline survey.
Title
Incidence Rate for Information-seeking Behavior by Intervention
Description
Incidence rate for Information-seeking behavior is the count of links demanded divided by the maximum possible count: 10
Time Frame
The outcome was measured immediately following the intervention in the 15-minute baseline survey.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Hispanic and African-American adult individuals, men and women - oversample of those with less completed education Exclusion Criteria: children, those who do not identify as above
Facility Information:
Facility Name
JPAL North America
City
Cambridge
State/Province
Massachusetts
ZIP/Postal Code
02138
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Generally, economists will post code and de-identified data when the findings are published
IPD Sharing Time Frame
Generally, social scientists post code and de-identified data when the findings are published
IPD Sharing Access Criteria
To be determined, if published alongside the paper data and code may be gated.
Citations:
PubMed Identifier
33347320
Citation
Alsan M, Stanford FC, Banerjee A, Breza E, Chandrasekhar AG, Eichmeyer S, Goldsmith-Pinkham P, Ogbu-Nwobodo L, Olken BA, Torres C, Sankar A, Vautrey PL, Duflo E. Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities : A Randomized Controlled Trial. Ann Intern Med. 2021 Apr;174(4):484-492. doi: 10.7326/M20-6141. Epub 2020 Dec 21.
Results Reference
derived

Learn more about this trial

COVID-19 Health Messaging to Underserved Communities

We'll reach out to this number within 24 hrs